Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Douglas A Cipkala"'
Autor:
Kristin Knight, Torunn I. Yock, Satkiran S. Grewal, Douglas A. Cipkala, Kay W. Chang, Johnnie K. Bass
Publikováno v:
Pediatric Blood & Cancer. 63:1152-1162
Hearing loss (HL) is common in childhood cancer survivors exposed to platinum chemotherapy and/or cranial radiation and can severely impact quality of life. Early detection and appropriate management can mitigate academic, speech, language, social, a
Publikováno v:
Laboratory Medicine. 45:253-258
Paroxysmal cold hemoglobinuria (PCH) is an acquired hemolytic anemia caused by immunoglobulin G (IgG) antibodies that sensitize red blood cells (RBCs) at cold temperatures by fixing complement to the RBCs causing intravascular hemolysis on rewarming.
Publikováno v:
Pediatric Blood & Cancer. 61:1104-1106
Patients 90% overall survival following treatment with chemotherapy and surgery. We report two infants with favorable biology, stage 4 neuroblastoma with refractory disease after standard intermediate-risk chemotherapy and additional retrieval chemot
Publikováno v:
Urology. 85(2)
We report a case of a 14-year-old boy who presented with gross hematuria and focal bilateral renal masses as presenting features of a mature high-grade B-cell leukemia, Burkitt subtype. The patient was treated with standard chemotherapy with the addi
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 74:278-285
Synthetic metalloporphyrin derivatives of heme have been identified as competitive inhibitors of heme oxygenase, the rate-limiting enzyme in the heme degradation pathway that produces equimolar quantities of carbon monoxide, biliverdin, and bilirubin
Publikováno v:
American journal of hypertension. 9(4 Pt 1)
Despite use as constitutive protein standards to quantify mRNA, data are limited regarding alteration of cyclophilin or glyceraldehyde-3-phosphate dehydrogenase (G3PDH) in hypertension or angiotensin converting enzyme (ACE) inhibitor treatment. We as
Publikováno v:
Journal of the American College of Cardiology. 25(2)
Constitutive protein mRNA is utilized as an index for target protein mRNA expression in experimental models. It is assumed that constitutive protein mRNA expression is not altered by disease states or pharmacologic intervention. We evaluated whether
Publikováno v:
Journal of Pediatric Hematology/Oncology. 27:464